Noticias de EXEL_US

Noticias del mercado

Últimas noticias sobre EXEL_US — 202 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: EXEL_US ✕ 202 resultados
20/04/2026 EXEL_US — MSN ES ← EN
Por qué Exelixis (EXEL) es una acción de alto valor a largo plazo

Why Exelixis (EXEL) is a top value stock for the long term

20/04/2026 EXEL_US — DirectorsTalk Interviews
Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader with Strong Growth Potential and 4.33% Upside
20/04/2026 EXEL_US — Yahoo Finance
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
20/04/2026 EXEL_US — AD HOC NEWS ES ← EN
Acciones de Exelixis Inc (US30161Q1040): ¿Es el dominio de Cabometyx lo suficientemente fuerte para un crecimiento oncológico sostenido?

Exelixis Inc stock (US30161Q1040): Is Cabometyx dominance strong enough for sustained oncology growt

19/04/2026 EXEL_US — AD HOC NEWS ES ← EN
Acciones de Exelixis Inc (US30161Q1040): ¿Es el crecimiento de Cabometyx lo suficientemente fuerte como para desbloquear nuevas ventajas?

Exelixis Inc stock (US30161Q1040): Is Cabometyx growth strong enough to unlock new upside?

17/04/2026 EXEL_US — MSN
Do Options Traders Know Something About Exelixis Stock We Don't?
17/04/2026 EXEL_US — MSN ES ← EN
He aquí por qué Exelixis (EXEL) es una acción de fuerte crecimiento
17/04/2026 EXEL_US — Yahoo Finance
Here's Why Exelixis (EXEL) is a Strong Growth Stock
16/04/2026 EXEL_US — Seeking Alpha
Exelixis: The Double Backbone Potential Of CABOMETYX And Zanzalintinib (NASDAQ:EXEL)
16/04/2026 EXEL_US — Yahoo Finance
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
16/04/2026 EXEL_US — Quiver Quantitative
EXEL | Exelixis Inc Executive Compensation
15/04/2026 EXEL_US — Quiver Quantitative
EXELIXIS, INC. ($EXEL) CEO 2025 Pay Revealed | EXEL Stock News
15/04/2026 EXEL_US — Stock Titan
Executive pay and equity plan on ballot at Exelixis (NASDAQ: EXEL) 2026 meeting
15/04/2026 EXEL_US — Seeking Alpha
Exelixis: Stable Demand And High Margins With Undervalued Shares (NASDAQ:EXEL)
15/04/2026 EXEL_US — Yahoo Finance
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
14/04/2026 EXEL_US — Markets Mojo
Exelixis, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators
03/04/2026 EXEL_US — Yahoo Finance
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
03/04/2026 EXEL_US — tayninh.gov.vn
EXEL Stock Analysis: Exelixis Inc. Minor Daily Dip and $44 Support Assessment
01/04/2026 EXEL_US — Eastern Progress ES ← EN
Exelixis publica resultados preliminares del 25 y publica perspectivas del 26
31/03/2026 EXEL_US — Yahoo Finance
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry

Página 9 de 11

keyboard_arrow_up